Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Product
Deals
Articles
BioCentury
|
Sep 8, 2008
Clinical News
S: Pivotal trial started
...pivotal STROLL trial in about 250 patients. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product:
S.M.A.R.T. stent
...
Read More
BioCentury
|
Jun 20, 2005
Clinical News
SMART Control Stent: Post-marketing study started
...JNJ subsidiary Cordis Corp. (Miami Lakes, Fla.) began the head-to-head German SUPER SL study comparing
SMART Control
...
...Hill, N.J.) markets Luminexx 6F vascular stent. Johnson & Johnson (JNJ), New Brunswick, N.J. Product:
SMART Control
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page